AF9 anticorps (N-Term)

N° du produit ABIN927717

Cet anticorps anti-AF9 est un anticorps Lapin Polyclonal détectant AF9 dans WB. Adapté pour Humain, Souris, Boeuf (Vache), Poisson zèbre (Danio rerio) et Xenopus laevis.

Aperçu rapide pour AF9 anticorps (N-Term) (ABIN927717)

Antigène: AF9 (MLLT3) (Protein AF-9 (MLLT3))

Reactivité: Humain, Souris, Boeuf (Vache), Poisson zèbre (Danio rerio), Xenopus laevis

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AF9 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-AF9 anticorps

Épitope: N-Term

Réactivité croisée: Souris, Boeuf (Vache), Poisson zebré (Brachydanio rerio), Grenouille

Purification: Purified

Immunogène: MLLT3 antibody was raised in rabbit using the N terminal of MLLT3 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

MLLT3 Blocking Peptide, (ABIN5614789), is also available for use as a blocking control in assays to test for specificity of this MLLT3 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur AF9

Antigène: AF9 (MLLT3) (Protein AF-9 (MLLT3))

Autre désignation: MLLT3

Sujet: MLLT3 is a regulator of early erythroid and megakaryocytic cell fate in the human system. Expression of MLLT3 in human CD34+ cells induces acute myeloid, lymphoid, or mixed-lineage leukemia in immunodeficient mice. Synonyms: Polyclonal MLLT3 antibody, Anti-MLLT3 antibody, myeloid/lymphoid or mixed-lineage leukemia, trithorax homolog, Drosophila, translocated to, 3 antibody, AF9 antibody, FLJ2035 antibody, YEATS3 antibody.